Search PubMed⌕ Search

Biomedical subjects

K Sawada

Publications and source records attributed to K Sawada.

At least 379 records · Page 21Linked to original sources
PubMed1983

[Pulmonary metastases from osteosarcoma].

On the basis of prognosis in conjunction with tumor behavior, 22 patients with pulmonary metastatic osteosarcoma who had a systematic with combination of surgery and adjuvant chemotherapy were compared with thirteen patients treated randomly in the initial period. The thirteen patients had median survival of 5 months with median tumor-free interval of 6 months. Six of the twenty two patients, however, are alive and 16 had median survival of 15 months with median tumor-free interval of 14 months. In 20 of the twenty two treated with repeated or bilateral thoracotomies, there was a correlation between decrease number of metastatic lesions with number of thoracotomies and survival. Wedge excision performed repeatedly produced only minimal loss of vital capacity, compared with lobectomy. Dn bloc resection of pericardium, chest wall, and diaphragm enhanced no survival. The patients with tumor-free interval of greater than 8 months survived or succumbed to the disease and was associated with mitotic ratio of more than 10 or less. Both of chest X-ray and CT scan had a positive diagnostic rate of 41% and 67%, respectively. Currently, we conclude that modified Thomfold 's indication is applicable to the patient with pulmonary metastatic osteosarcoma with bilateral or multiple nodules and more than 8 months of tumor-free interval.

Adolescent↗
PubMed1983

[Case of simultaneous triple cancers of the duodenal papilla, gallbladder and stomach].

The patient was a 76-year-old man with simultaneous triple cancer arising in the duodenal papilla, gallbladder and stomach, whose complaint was epigastralgia. Endoscopic and radiologic studies revealed early gastric cancer (IIc) at the posterior wall of the antrum; ERCP disclosed obstruction with "apple core" appearance in the distal bile duct. Pancreaticoduodenectomy, cholecystectomy and distal gastrectomy with lymph node dissection were performed. Histopathological examination of the resected specimens revealed papillo-tubular adenocarcinoma in the duodenal papilla, well differetiated tubular adenocarcinoma in the gallbladder, and moderately differentiated tubular adenocarcinoma in the gastric mucosa.

Adenocarcinoma↗
PubMed1983

[Clinical experience in patients with Pancoast's tumor treated by fast neutron therapy].

We review our results with fast neutron therapy in Pancoast's tumor, and compare them with results obtained by photon beam therapy. 13 patients with Pancoast's tumor were divided into two groups; Group I (8 patients) received fast neutron therapy. Group II (5 patients) were treated by voltage X-ray therapy. 1. Group I was comprised of 3 patients receiving mixed beam therapy (TDF 80-100) and 5 patients subjected to boost therapy. All group II patients received 3100 to 8000 rads. 2. Fast neutron therapy was effective in 7 patients. In group II, high voltage X-ray therapy was effective in only 3 patients. 3. Two group I patients are still alive without signs of recurrence. The others died with a mean survival of 11 months. All group II patients died; their mean survival was 4.2 months. Our results suggest that fast neutron therapy is suitable and effective in patients with Pancoast's tumor.

Adenoma↗
PubMed1982

Prosthetic replacement of entire left hemidiaphragm in malignant fibrous histiocytoma of the diaphragm.

A case of primary malignant fibrous histiocytoma of the diaphragm which, to our knowledge, is the first record in the world literature, is presented. It occupied almost the entire left hemidiaphragm and was surgically removed with the left lower pulmonary lobe, stomach, colon, and spleen. The entire left hemidiaphragm then was replaced with Marlex mesh. Prosthetic replacement of the entire hemidiaphragm, which has not been previously reported, was successfully performed with preservation of pulmonary function on the affected side. The patient died of brain metastases of malignant fibrous histiocytoma more than 4 months postoperatively. Diagnosis of diaphragmatic tumors and a technique which involves the use of a prosthesis are discussed.

Brain Neoplasms↗
PubMed1982

Neutral glycosphingolipids and gangliosides of bovine thyroid.

By the application of a ganglioside-mapping technique, the lipid composition of bovine thyroid was analyzed systematically. The contents of cholesterol, lipid-bound phosphorus and lipid-bound sialic acid in bovine thyroid were 5.10, 9.76, and 0.28 mumol/g of dry tissue, respectively, and the molar ratio of cholesterol, lipid-bound sialic acid, and lipid-bound phosphorus was 52.4 : 2.9 : 100.0. The following phospholipids were contained in this order: phosphatidylcholine greater than phosphatidylethanolamine greater than sphingomyelin greater than phosphatidylserine and phosphatidylinositol greater than cardiolipin. When compared on a molar basis, the amount of total glycosphingolipids was only 3% of phospholipids. As the major neutral glycosphingolipids, ceramide glucoside, ceramide galactoside, ceramide lactoside, ceramide trihexoside and globoside were identified and the most abundant component was globoside (40% of total neutral glycosphingolipids). On the other hand, five molecular species of gangliosides were identified: GM3, GM1, fucosyl GM1, GD3, and GD1a. Three types of GD3 and GD1a with a different sialic acid composition were recognized on the ganglioside-map and isolated in pure forms. GM3 was the most abundant component, but the concentration of gangliosides with ganglio-N-tetraose in bovine thyroid was higher than that of gangliosides with lactose. Also fucosyl GM1 comprised 13% of total gangliosides. Thus, the high concentrations of gangliosides with ganglio-N-tetraose and fucosyl GM1 seemed to be characteristic of bovine thyroid glycosphingolipids. The glycosphingolipids contained in the following order: GM3 greater than GD1a greater than globoside greater than GM1 greater than ceramide trihexoside greater than fucosyl GM1 greater than ceramide lactoside greater than ceramide glycoside greater than GD3 greater than ceramide galactoside.

Animals↗